Effect of selexipag on long-term outcomes in key subgroups of patients with pulmonary arterial hypertension (PAH): GRIPHON study results

被引：1

作者：

Sitbon, Olivier ^{[1
]}

Channick, Richard ^{[2
]}

Chin, Kelly ^{[3
]}

Frey, Aline ^{[4
]}

Galie, Nazzareno ^{[5
]}

Ghofrani, Hossein-Ardeschir ^{[6
]}

Hoeper, Marius M. ^{[7
,8
]}

Lang, Irene ^{[9
]}

Le Brun, Franck-Olivier ^{[4
]}

McLaughlin, Vallerie ^{[10
]}

Preiss, Ralph ^{[4
]}

Rubin, Lewis J. ^{[11
]}

Simonneau, Gerald ^{[1
]}

Tapson, Victor ^{[12
]}

Gaine, Sean ^{[13
]}

机构：

[1] Univ Paris Sud, Hop Univ Bicetre, Le Kremlin Bicetre, France

[2] Massachusetts Gen Hosp, Pulm & Crit Care, Boston, MA 02114 USA

[3] Univ Texas Southwestern Med Ctr Dallas, Pulm Hypertens Program, Dallas, TX 75390 USA

[4] Actel Pharmaceut Ltd, Clin Res, Allschwil, Switzerland

[5] Univ Bologna, Ist Malattie Apparato Cardiovasc, Bologna, Italy

[6] UGMLC, Giessen, Germany

[7] Hannover Med Sch, Dept Resp Med, Hannover, Germany

[8] German Ctr Lung Res, Hannover, Germany

[9] Med Univ Vienna, AKH, Dept Internal Med 2, Div Cardiol, Vienna, Austria

[10] Univ Michigan Hlth Syst, Div Cardiovasc Med, Ann Arbor, MI USA

[11] Univ Calif San Diego, Div Pulm & Crit Care Med, San Diego, CA 92103 USA

[12] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA

[13] Mater Misericordiae Univ Hosp, Natl Pulm Hypertens Unit, Dublin, Ireland

来源：

EUROPEAN RESPIRATORY JOURNAL | 2015年 / 46卷

关键词：

Pulmonary hypertension;

D O I：

10.1183/13993003.congress-2015.OA4995

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

OA4995

引用

页数：3

共 50 条

[21] Early selexipag initiation and long-term outcomes: insights from randomised controlled trials in pulmonary arterial hypertension
Coghlan, J. Gerry
Gaine, Sean
Channick, Richard
Chin, Kelly M.
du Roure, Camille
Gibbs, J. Simon R.
Hoeper, Marius M.
Lang, Irene M.
Mathai, Stephen C.
McLaughlin, Vallerie V.
Mitchell, Lada
Simonneau, Gerald
Sitbon, Olivier
Tapson, Victor F.
Galie, Nazzareno
ERJ OPEN RESEARCH, 2023, 9 (01)
[22] Hemodynamics in pulmonary arterial hypertension (PAH): do they explain long-term clinical outcomes with PAH-specific therapy?
Peter Steele
Geoff Strange
John Wlodarczyk
Brad Dalton
Simon Stewart
Eli Gabbay
Anne Keogh
BMC Cardiovascular Disorders, 10
[23] Hemodynamics in pulmonary arterial hypertension (PAH): do they explain long-term clinical outcomes with PAH-specific therapy?
Steele, Peter
Strange, Geoff
Wlodarczyk, John
Dalton, Brad
Stewart, Simon
Gabbay, Eli
Keogh, Anne
BMC CARDIOVASCULAR DISORDERS, 2010, 10
[24] Long-term therapeutic outcomes in pulmonary arterial hypertension
Galie, Nazzareno
Hirani, Naushad
Manes, Alessandra
Romanazzi, Serena
Palazzini, Massimiliano
Negro, Luca
Branzi, Angelo
CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 : S11 - S18
[25] Changes in REVEAL Lite 2 risk status are associated with long-term outcomes in patients with pulmonary arterial hypertension: A post-hoc analysis of the GRIPHON study
Benza, Raymond L.
Chin, Kelly M.
Gaine, Sean
Galie, Nazzareno
Hoeper, Marius M.
Lang, Irene M.
V. McLaughlin, Vallerie
Sitbon, Olivier
Doad, Gurinderpal
Yen, Joseph
Tang, Xiaoqin
Tapson, Victor
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (12): : 1998 - 2007
[26] The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study (vol 24, pg 205, 2022)
Rosenkranz, Stephan
Channick, Richard
Chin, Kelly M.
Jenner, Bartosz
Gaine, Sean
Galie, Nazzareno
Ghofrani, Hossein-Ardeschir
Hoeper, Marius M.
McLaughlin, Vallerie V.
Du Roure, Camille
Rubin, Lewis J.
Sitbon, Olivier
Tapson, Victor
Lang, Irene M.
EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (08) : 1453 - 1453
[27] The Long-Term Outcomes In Patients With Exercise-Induced Pulmonary Arterial Hypertension
Huang, W.
Systrom, D.
Waxman, A.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
[28] Selexipag for pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) after defect correction: insights from the randomized controlled GRIPHON study
Beghetti, M.
Channick, R.
Chin, K.
Di Scala, L.
Gaine, S.
Ghofrani, H. A.
Hoeper, M.
Lang, I.
McLaughlin, V.
Preiss, R.
Rubin, L.
Simonneau, G.
Sitbon, O.
Tapson, V.
Galie, N.
EUROPEAN HEART JOURNAL, 2016, 37 : 1243 - 1243
[29] Idiopathic Pulmonary Arterial Hypertension in Asians A Long-term Study on Clinical Outcomes
Tan, Genevieve M. Y.
Tay, Edgar L.
Tai, Bee-Choo
Yip, James W. L.
CHEST, 2015, 147 (04) : E160 - E163
[30] Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)
Preston, Ioana R.
Roberts, Kari E.
Miller, Dave P.
Sen, Ginny P.
Selej, Mona
Benton, Wade W.
Hill, Nicholas S.
Farber, Harrison W.
CIRCULATION, 2015, 132 (25) : 2403 - 2411

← 1 2 3 4 5 →